Cargando…

Praziquantel Synergistically Enhances Paclitaxel Efficacy to Inhibit Cancer Cell Growth

The major challenges we are facing in cancer therapy with paclitaxel (PTX) are the drug resistance and severe side effects. Massive efforts have been made to overcome these clinical challenges by combining PTX with other drugs. In this study, we reported the first preclinical data that praziquantel...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zhen Hua, Lu, Ming-ke, Hu, Long Yu, Li, Xiaotong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520897/
https://www.ncbi.nlm.nih.gov/pubmed/23251610
http://dx.doi.org/10.1371/journal.pone.0051721